(VIANEWS) – Enphase Energy (ENPH), Horizon Therapeutics (HZNP), Zynex (ZYXI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Enphase Energy (ENPH)

40% sales growth and 18.45% return on equity

Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally.

Enphase Energy’s sales growth this year is anticipated to be 72.3% and 35.5% for next year.

Year-on-year quarterly revenue growth grew by 46.8%, now sitting on 870.63M for the twelve trailing months.

Volume

Today’s last reported volume for Enphase Energy is 2750930 which is 17.99% below its average volume of 3354560.

Enphase Energy’s sales growth for the next quarter is 40%. The company’s growth estimates for the ongoing quarter and the next is 60% and 3.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.45%.

Volatility

Enphase Energy’s last day, last week, and last month’s current intraday variation average was 4.47%, 3.71%, and 4.64%, respectively.

Enphase Energy’s highest amplitude of average volatility was 9.06% (day), 9.07% (last week), and 7.94% (last month), respectively.

Enphase Energy’s Stock Yearly Top and Bottom Value

Enphase Energy’s stock is valued at $171.07 at 19:22 EST, way below its 52-week high of $282.46 and way higher than its 52-week low of $108.88.

Enphase Energy’s Moving Average

Enphase Energy’s value is way below its 50-day moving average of $213.55 and below its 200-day moving average of $172.52.

Previous days news about Enphase Energy(ENPH)

  • Here's how much you would have made owning enphase energy stock in the last 10 years. According to Benzinga on Tuesday, 8 March, "Buying $100 In ENPH: 10 years ago, an investor could have purchased 13.62 shares of Enphase Energy at the time with $100. ", "If you had invested $100 in Enphase Energy you would have approximately $2,403.34 today."

2. Horizon Therapeutics (HZNP)

27.5% sales growth and 16.1% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics’s sales growth this year is expected to be 41.2% and 23.5% for next year.

Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.

Volume

Today’s last reported volume for Horizon Therapeutics is 1344330 which is 18.11% below its average volume of 1641750.

Horizon Therapeutics’s sales growth for the next quarter is 27.5%. The company’s growth estimates for the present quarter and the next is a negative 11.5% and 10.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.1%.

Volatility

Horizon Therapeutics’s last day, last week, and last month’s current intraday variation average was 0.36%, 0.72%, and 1.38%, respectively.

Horizon Therapeutics’s highest amplitude of average volatility was 1.90% (day), 2.49% (last week), and 2.85% (last month), respectively.

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $100.76 at 19:22 EST, way under its 52-week high of $120.54 and way above its 52-week low of $66.41.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s value is below its 50-day moving average of $109.80 and above its 200-day moving average of $100.05.

3. Zynex (ZYXI)

21.7% sales growth and 26.16% return on equity

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Zynex’s sales growth this year is expected to be 22.6% and 25.8% for next year.

Year-on-year quarterly revenue growth grew by 57.6%, now sitting on 130.3M for the twelve trailing months.

Volume

Today’s last reported volume for Zynex is 251594 which is 38.24% below its average volume of 407432.

Zynex’s sales growth for the next quarter is 21.7%. The company’s growth estimates for the current quarter and the next is 350% and 57.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.16%.

Volatility

Zynex’s last day, last week, and last month’s current intraday variation average was 1.20%, 4.70%, and 3.80%, respectively.

Zynex’s highest amplitude of average volatility was 4.67% (day), 7.63% (last week), and 8.25% (last month), respectively.

Zynex’s Stock Yearly Top and Bottom Value

Zynex’s stock is valued at $5.92 at 19:22 EST, way below its 52-week high of $16.26 and way above its 52-week low of $5.20.

Zynex’s Moving Average

Zynex’s worth is way under its 50-day moving average of $7.64 and way below its 200-day moving average of $11.25.

4. Ryder System (R)

20.1% sales growth and 20.64% return on equity

Ryder System, Inc. provides transportation and supply chain management solutions worldwide.

Ryder System’s sales growth this year is anticipated to be 12.4% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 9.66B for the twelve trailing months.

Volume

Today’s last reported volume for Ryder System is 649269 which is 8.83% above its average volume of 596536.

Ryder System’s sales growth for the next quarter is 20.1%. The company’s growth estimates for the current quarter and the next is 113.8% and 20%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.64%.

Volatility

Ryder System’s last day, last week, and last month’s current intraday variation average was 2.25%, 2.25%, and 2.01%, respectively.

Ryder System’s highest amplitude of average volatility was 6.85% (day), 4.55% (last week), and 3.64% (last month), respectively.

Ryder System’s Stock Yearly Top and Bottom Value

Ryder System’s stock is valued at $75.59 at 19:22 EST, way under its 52-week high of $93.05 and way above its 52-week low of $67.03.

Ryder System’s Moving Average

Ryder System’s worth is below its 50-day moving average of $77.20 and below its 200-day moving average of $79.46.

Previous days news about Ryder System(R)

  • According to MarketWatch on Thursday, 10 March, "Meanwhile, the transports’ decliners were led by the 1.4% drop in air carrier Delta Air Lines Inc.’s stock and the 1.3% drop in truck rental company Ryder System Inc.’s stock ."

5. Washington Federal (WAFD)

15.9% sales growth and 9.26% return on equity

Washington Federal, Inc. operates as the bank holding company for Washington Federal Bank, National Association that provides lending, depository, insurance, and other banking services in the United States.

Washington Federal’s sales growth this year is anticipated to be 17.7% and 8.2% for next year.

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 599.89M for the twelve trailing months.

Volume

Today’s last reported volume for Washington Federal is 453529 which is 10.25% below its average volume of 505363.

Washington Federal’s sales growth is a negative 0% for the ongoing quarter and 15.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 25% and 19.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.26%.

Volatility

Washington Federal’s last day, last week, and last month’s current intraday variation average was 0.42%, 2.61%, and 1.52%, respectively.

Washington Federal’s highest amplitude of average volatility was 2.09% (day), 3.46% (last week), and 2.56% (last month), respectively.

Washington Federal’s Stock Yearly Top and Bottom Value

Washington Federal’s stock is valued at $35.35 at 19:22 EST, under its 52-week high of $38.06 and way higher than its 52-week low of $29.01.

Washington Federal’s Moving Average

Washington Federal’s worth is higher than its 50-day moving average of $35.06 and above its 200-day moving average of $33.82.

6. Choice Hotels International (CHH)

11.1% sales growth and 222.16% return on equity

Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide.

Choice Hotels International’s sales growth this year is anticipated to be 13.5% and 6.8% for next year.

Year-on-year quarterly revenue growth grew by 47.2%, now sitting on 1.07B for the twelve trailing months.

Volume

Today’s last reported volume for Choice Hotels International is 265506 which is 12.09% below its average volume of 302045.

Choice Hotels International’s sales growth for the next quarter is 11.1%. The company’s growth estimates for the ongoing quarter and the next is 61.4% and 12.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 222.16%.

Volatility

Choice Hotels International’s last day, last week, and last month’s current intraday variation average was 0.59%, 2.80%, and 2.08%, respectively.

Choice Hotels International’s highest amplitude of average volatility was 3.09% (day), 4.52% (last week), and 3.55% (last month), respectively.

Choice Hotels International’s Stock Yearly Top and Bottom Value

Choice Hotels International’s stock is valued at $135.22 at 19:22 EST, way below its 52-week high of $157.46 and way higher than its 52-week low of $103.06.

Choice Hotels International’s Moving Average

Choice Hotels International’s worth is below its 50-day moving average of $145.93 and above its 200-day moving average of $133.27.

LEAVE A REPLY

Please enter your comment!
Please enter your name here